US Broker Ratings

Regeneron Pharmaceuticals (REGN) Stock Analysis: Navigating a Biotech Leader’s Growth Potential and Analyst Ratings

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a stalwart in the biotechnology sector, continues to capture investor attention with its diverse portfolio of innovative treatments and strategic collaborations. With a market capitalization..

argenx SE (ARGX)

⚠️ No article content returned.

..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a 10% Potential Upside with Strong Buy Ratings

Gilead Sciences, Inc. (NASDAQ: GILD) stands out in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $178.21 billion, Gilead is a titan in the..

Becton, Dickinson and Company (BDX) Stock Analysis: A Healthcare Giant with a 10% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is capturing investor attention with its strategic position in the medical instruments and supplies industry. Headquartered in Franklin..

ResMed Inc. (RMD) Stock Analysis: Exploring 12.90% Potential Upside in the Healthcare Sector

ResMed Inc. (RMD), a prominent player in the healthcare sector, is making waves with its innovative approach to digital health and cloud-connected medical devices. With a market capitalization of $31.49..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 29% Potential Upside

For investors seeking exposure to the healthcare sector, Intuitive Surgical, Inc. (NASDAQ: ISRG) presents a compelling opportunity, particularly with a potential upside of 29.04% based on current analyst ratings. As..

Eli Lilly and Company (LLY)

⚠️ No article content returned.

..

Edwards Lifesciences Corp (EW) Stock Analysis: A Potential 19.67% Upside in the Healthcare Sector

For investors looking to capitalize on opportunities within the healthcare sector, Edwards Lifesciences Corporation (NYSE: EW) presents an intriguing prospect. With a substantial market capitalization of $48.63 billion, this medical..

AstraZeneca PLC (AZN) Stock Analysis: A 32.92% Upside Potential Beckons Investors

AstraZeneca PLC (AZN), a leading player in the healthcare sector, has been capturing investor attention with its robust pipeline and promising growth potential. Trading on the New York Stock Exchange,..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 29% Upside with Strong Buy Ratings

Alcon Inc. (NYSE: ALC), a stalwart in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. Based in Switzerland, Alcon specializes in eye care products,..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating Growth and Valuation Metrics

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, commands a significant market presence with a market cap of $90.81 billion. This Indianapolis-based company, formerly known..

Vertex Pharmaceuticals Incorpor (VRTX) Stock Analysis: Understanding the 10.43% Upside Potential

For investors seeking opportunities in the biotechnology sector, Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) presents a compelling case. With a market capitalization of $130.64 billion, Vertex stands as a formidable player..

McKesson Corporation (MCK) Investor Outlook: Analyzing a Potential 11.26% Upside in the Healthcare Giant

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to capture investor interest with its robust market presence and promising growth potential. With a market capitalization north of..

Amgen Inc. (AMGN) Stock Analysis: Navigating Market Dynamics with a Strong 91.47% Return on Equity

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, particularly in the drug manufacturing industry, continues to capture investor attention with its robust financial performance and strategic market positioning...

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and Promising Growth in Healthcare

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a leader in..

Johnson & Johnson (JNJ) Stock Analysis: Strong Investor Confidence with 16 Buy Ratings and a 4.64% Potential Upside

Johnson & Johnson, trading under the ticker symbol JNJ, stands as a formidable entity in the healthcare sector, boasting a market capitalization of $640.02 billion. This American giant, based in..

Alkermes plc (ALKS) Investor Outlook: Strong Buy Ratings and 21% Potential Upside

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, is drawing significant attention from investors due to its robust performance metrics and growth potential. Headquartered in Dublin, Ireland,..

Bausch + Lomb Corporation (BLCO) Investor Outlook: Eyeing a 3.24% Upside Amid Diverse Global Operations

Bausch + Lomb Corporation (NYSE: BLCO), a venerable player in the healthcare sector, is renowned for its comprehensive suite of eye health products and services. With a market capitalization of..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 32.85% Upside in Healthcare Information Services

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare information services sector with its innovative cloud-based software solutions aimed at streamlining healthcare payments. With a market capitalization of..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring an 18% Potential Upside in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH) stands out as a noteworthy player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $3.63 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds